Literature DB >> 17563566

Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.

Gian Paolo Rossi1, Anna Belfiore, Giampaolo Bernini, Giovambattista Desideri, Bruno Fabris, Claudio Ferri, Gilberta Giacchetti, Claudio Letizia, Mauro Maccario, Francesca Mallamaci, Massimo Mannelli, Domenico Montemurro, Gaetana Palumbo, Damiano Rizzoni, Ermanno Rossi, Andrea Semplicini, Enrico Agabiti-Rosei, Achille Cesare Pessina, Franco Mantero.   

Abstract

BACKGROUND: Data on the performance of the tests used to confirm the diagnosis of primary aldosteronism (PA) are limited.
OBJECTIVE: To prospectively investigate the accuracy of the saline infusion test (SIT).
METHODS: Three hundred and seventeen (26.9%) out of 1125 patients screened in the PAPY study underwent measurement of plasma aldosterone, cortisol and renin activity after infusion of 2 l of isotonic saline intravenously over 4 h. They comprised patients with a baseline aldosterone/renin ratio (ARR) > 40 and one every four patients not fulfilling such criterion. The area under the receiver-operator characteristic curves (AUC) of aldosterone values after SIT was used as a measure of accuracy for diagnosing PA, aldosterone-producing adenoma (APA) or idiopathic hyperaldosteronism (IHA).
RESULTS: One hundred and twenty (37.9%) patients had PA that was due to an APA in 46 (38.3%) and to IHA in 74 (61.7%). No untoward effect occurred with the SIT. The AUC (0.811 +/- 0.026, 0.878 +/- 0.040 and 0.784 +/- 0.034 for identification of PA, APA and IHA, respectively) was higher (P < 0.0001) than that under the diagonal. By sensitivity/specificity versus criterion values plot, the best aldosterone cut-off values for identifying APA and IHA were 6.75 and 6.91 ng/dl, respectively. However, even at these optimal cut-offs, sensitivity and specificity were moderate because of values overlapping between patients with and without the disease. Moreover, there were no differences of AUC and aldosterone cut-offs between APA and IHA.
CONCLUSION: In a multicenter study the SIT was safe and specific for excluding PA, but had no place for discriminating between an APA and IHA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17563566     DOI: 10.1097/HJH.0b013e328126856e

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  26 in total

1.  Cardiovascular changes in patients with primary aldosteronism after surgical or medical treatment.

Authors:  G Bernini; A Bacca; V Carli; D Carrara; G Materazzi; P Berti; P Miccoli; R Pisano; V Tantardini; M Bernini; S Taddei
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

Review 2.  Primary aldosteronism: A contrarian view.

Authors:  Norman M Kaplan
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

3.  Shortened saline infusion test for subtype prediction in primary aldosteronism.

Authors:  Kazutaka Nanba; Mika Tsuiki; Hironobu Umakoshi; Aya Nanba; Yuusuke Hirokawa; Takeshi Usui; Tetsuya Tagami; Akira Shimatsu; Tomoko Suzuki; Akiyo Tanabe; Mitsuhide Naruse
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

4.  Value of adrenal venous sampling for lesion localization in primary aldosteronism.

Authors:  Eun Mee Oh; Kyu Eun Lee; Kwan Yoon; Seong Yeon Kim; Hyo-Cheol Kim; Yeo-Kyu Youn
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

5.  Primary Aldosteronism and ARMC5 Variants.

Authors:  Mihail Zilbermint; Paraskevi Xekouki; Fabio R Faucz; Annabel Berthon; Alexandra Gkourogianni; Marie Helene Schernthaner-Reiter; Maria Batsis; Ninet Sinaii; Martha M Quezado; Maria Merino; Aaron Hodes; Smita B Abraham; Rossella Libé; Guillaume Assié; Stéphanie Espiard; Ludivine Drougat; Bruno Ragazzon; Adam Davis; Samson Y Gebreab; Ryan Neff; Electron Kebebew; Jérôme Bertherat; Maya B Lodish; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2015-03-30       Impact factor: 5.958

Review 6.  A comprehensive review of the clinical aspects of primary aldosteronism.

Authors:  Gian Paolo Rossi
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

7.  Adrenalectomy for Primary Aldosteronism: Significant Variability in Work-Up Strategies and Low Guideline Adherence in Worldwide Daily Clinical Practice.

Authors:  Wessel M C M Vorselaars; Dirk-Jan van Beek; Diederik P D Suurd; Emily Postma; Wilko Spiering; Inne H M Borel Rinkes; Gerlof D Valk; Menno R Vriens
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

8.  Comparison of the shortened and standard saline infusion tests for primary aldosteronism diagnostics.

Authors:  Kaoru Yamashita; Midori Yatabe; Yasufumi Seki; Kanako Bokuda; Daisuke Watanabe; Satoru Shimizu; Satoshi Morimoto; Atsuhiro Ichihara
Journal:  Hypertens Res       Date:  2020-05-08       Impact factor: 3.872

Review 9.  Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.

Authors:  Laurence Amar; Pierre-François Plouin; Olivier Steichen
Journal:  Orphanet J Rare Dis       Date:  2010-05-19       Impact factor: 4.123

Review 10.  Progress in primary aldosteronism: present challenges and perspectives.

Authors:  C E Gomez-Sanchez; G P Rossi; F Fallo; M Mannelli
Journal:  Horm Metab Res       Date:  2010-01-20       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.